Artificial Intelligence Based Timing, Infarct Size and Outcomes in Acute Coronary Occlusion Myocardial Infarction

Recruiting Observational Study
Coronary Arterial Disease (CAD) Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,500 (estimated)
Sponsor
Azienda Ospedaliera di Bolzano · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The present study is practice-driven and merely observational and prospective. In clinical routine, patients who suffer from suspected ACS and do not show ST elevation in the ECG, different timing proposals in the guidelines and logistically driven differences lead to considerably variable timings in invasive coronary anatomy assessments. This handling may lead to larger infarct sizes when OMI is …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age \> 18 yrs * Working diagnosis of Non- ST Elevation Acute Coronary Syndrome after the assessment by specialist Exclusion Criteria: * ST-Elevation Myocardial infarction * Age \< 18 yrs * Major sustained ventricular arrhythmias * Corrupted ECG images * Poor digitalisation q…
Contacts

Matthias Unterhuber, MD, Associate Prof.

+39 471 43 9950

matthias.unterhuber@gmail.com

CONTACT